Related Experiment Video

Updated: Dec 23, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

14.0K

Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth

Catherine E Gatza1, Alisha Holtzhausen, Kellye C Kirkbride

  • 1Department of Medicine, Duke University Medical Center, Durham, NC 27708, USA.

Neoplasia (New York, N.Y.)
|August 18, 2011
PubMed

Insights

Type III TGF-β receptor (TβRIII) protein levels increase in colon cancer, promoting tumor cell proliferation, migration, and resistance to apoptosis. This contrasts with other cancers, highlighting a distinct role for TβRIII in colon cancer progression.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Signaling

Background:

  • Type III TGF-β receptor (TβRIII), also known as betaglycan, is a coreceptor in the TGF-β superfamily.
  • Altered TGF-β signaling is implicated in colon cancer, but TβRIII's specific role remains unclear.
  • TβRIII is often downregulated in cancers, typically suppressing tumor progression.

Purpose of the Study:

  • To investigate the role of TβRIII in colon cancer progression.
  • To determine if TβRIII expression patterns and functions in colon cancer differ from other cancer types.

Main Methods:

  • Analysis of TβRIII mRNA and protein expression in colon cancer.
  • Manipulation of TβRIII expression in colon cancer cell models.
  • Assessment of signaling pathway activation (p38, Smad).
  • Evaluation of cellular proliferation, apoptosis, migration, and in vivo tumorigenicity.

Main Results:

  • TβRIII mRNA levels were not significantly altered, but protein levels were frequently increased in colon cancer.
  • Increased TβRIII enhanced ligand-induced p38 and Smad phosphorylation.
  • TβRIII switched TGF-β and BMP-2 from inhibitory to stimulatory roles in colon cancer cell proliferation.
  • Overexpression of TβRIII promoted anchorage-independent growth, chemoresistance, increased migration, and tumorigenicity in vivo.

Conclusions:

  • TβRIII plays a distinct, pro-tumorigenic role in colon cancer, unlike its suppressive role in other cancers.
  • TβRIII mediates TGF-β superfamily ligand-induced colon cancer progression.
  • TβRIII's function in cancer is context-dependent.

More Related Videos

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

11.0K
Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

22.3K

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.3K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K